Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 40.83%968.7M | 4.17%3.06B | 13.75%890.21M | -16.30%755.16M | 20.12%729M | 6.14%687.85M | 13.37%2.94B | 17.43%782.61M | 59.77%902.19M | -9.48%606.9M |
| Cost of revenue | 32.08%480.5M | -11.38%1.7B | -6.77%602.28M | -28.67%396.35M | 0.74%341.06M | -4.79%363.81M | 28.35%1.92B | 44.19%646.01M | 73.24%555.66M | 0.10%338.57M |
| Gross profit | 50.66%488.2M | 33.55%1.36B | 110.79%287.93M | 3.54%358.81M | 44.58%387.94M | 21.85%324.05M | -7.12%1.02B | -37.47%136.6M | 42.06%346.54M | -19.23%268.33M |
| Operating expense | -422.00%-330.04M | 69.69%-365.8M | 50.44%-752.93M | 11.25%133.7M | 53.74%150.94M | 8.94%102.5M | -567.08%-1.21B | -4,475.90%-1.52B | 11.72%120.19M | 0.25%98.18M |
| Selling and administrative expenses | 32.56%125.16M | 23.72%453.21M | 29.64%151.26M | 12.70%101.56M | 29.78%105.97M | 21.24%94.42M | 15.61%366.32M | 42.40%116.67M | 8.90%90.12M | 3.95%81.65M |
| -Selling and marketing expense | 6.34%30.96M | 75.87%160.69M | 152.13%70.85M | 9.54%26.98M | 69.85%33.75M | 55.11%29.11M | 20.76%91.37M | 54.14%28.1M | 14.26%24.63M | -4.13%19.87M |
| -General and administrative expense | 44.24%94.2M | 6.39%292.52M | -9.22%80.41M | 13.88%74.58M | 16.90%72.22M | 10.48%65.31M | 13.99%274.95M | 39.04%88.57M | 7.01%65.49M | 6.85%61.78M |
| Other operating expenses | 44.35%79.55M | -36.36%267.21M | -72.56%76.94M | 8.43%61.38M | 71.68%73.78M | 38.30%55.11M | 31.02%419.86M | 81.28%280.43M | 16.17%56.6M | -3.68%42.98M |
| Total other operating income | 1,037.05%534.74M | -45.50%1.09B | -48.80%981.13M | 10.17%29.24M | 8.94%28.82M | 98.95%47.03M | 143.57%1.99B | 610.18%1.92B | 11.02%26.54M | 4.84%26.45M |
| Operating profit | 269.32%818.24M | -22.46%1.72B | -37.14%1.04B | -0.55%225.1M | 39.29%237M | 28.91%221.55M | 74.27%2.22B | 558.00%1.66B | 66.00%226.35M | -27.37%170.15M |
| Net non-operating interest income (expenses) | 17.77%-79.85M | -1,514.36%-379.22M | -961.22%-80.26M | -1,052.90%-100.83M | -1,124.01%-101.03M | -797.18%-97.1M | -42.55%26.81M | -162.63%-7.56M | -15.66%10.58M | -23.19%9.87M |
| Non-operating interest income | 34.73%15.78M | -14.87%38.95M | -12.90%9.4M | -25.09%7.97M | -1.72%9.87M | -18.01%11.71M | -7.56%45.75M | -16.20%10.79M | -19.88%10.63M | -25.78%10.05M |
| Non-operating interest expense | -12.12%95.63M | 2,383.73%400.97M | 388.61%89.66M | 205,167.92%108.79M | 61,172.38%110.9M | 30,465.73%108.81M | 555.73%16.14M | 4,118.16%18.35M | -92.71%53K | -73.88%181K |
| Total other finance cost | ---- | 515.06%17.19M | ---- | ---- | ---- | ---- | 674.24%2.8M | ---- | ---- | ---- |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 64.93%15.26M | 141.16%109.14M | 686.62%62.94M | 31.55%22.13M | 2,881.99%14.83M | -76.70%9.25M | -84.75%45.26M | -127.27%-10.73M | 248.10%16.82M | -100.24%-533K |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 463.69%753.64M | -36.66%1.45B | -37.49%1.02B | -42.30%146.41M | -15.98%150.8M | -40.71%133.7M | 41.76%2.3B | 440.33%1.64B | 65.06%253.75M | -62.07%179.49M |
| Income tax | 36.62%86.7M | 68.59%385.04M | 114.79%198.61M | 113.74%68.67M | -0.95%54.29M | 29.57%63.46M | 4.08%228.39M | 41.55%92.47M | -12.44%32.13M | -19.87%54.81M |
| Net income | 849.60%666.94M | -48.28%1.07B | -46.61%824.93M | -64.93%77.73M | -22.59%96.51M | -60.21%70.23M | 47.67%2.07B | 549.91%1.55B | 89.36%221.62M | -69.21%124.67M |
| Net income continuous operations | 849.60%666.94M | -48.28%1.07B | -46.61%824.93M | -64.93%77.73M | -22.59%96.51M | -60.21%70.23M | 47.67%2.07B | 549.91%1.55B | 89.36%221.62M | -69.21%124.67M |
| Noncontrolling interests | 144.98%2.61M | -10.68%5.4M | 265.02%1M | 13.64%1.6M | -45.52%1.73M | -48.33%1.07M | -17.72%6.04M | -125.69%-606K | -15.33%1.41M | 10.46%3.18M |
| Net income attributable to the company | 860.45%664.33M | -48.39%1.06B | -46.69%823.93M | -65.43%76.13M | -21.99%94.78M | -60.35%69.17M | 48.01%2.06B | 556.68%1.55B | 90.87%220.21M | -69.78%121.5M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 860.45%664.33M | -48.39%1.06B | -46.69%823.93M | -65.43%76.13M | -21.99%94.78M | -60.35%69.17M | 48.01%2.06B | 556.68%1.55B | 90.87%220.21M | -69.78%121.5M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 857.94%0.1207 | -48.41%0.1932 | -46.72%0.1496 | -65.50%0.0138 | -22.17%0.0172 | -60.25%0.0126 | 48.02%0.3745 | 556.07%0.2808 | 90.48%0.04 | -69.73%0.0221 |
| Diluted earnings per share | 857.94%0.1207 | -48.41%0.1932 | -46.72%0.1496 | -65.50%0.0138 | -22.17%0.0172 | -60.25%0.0126 | 48.02%0.3745 | 556.07%0.2808 | 90.48%0.04 | -69.73%0.0221 |
| Dividend per share | 0.08 | 0.00%0.05 | 0 | 0 | 0.05 | 0 | 25.00%0.05 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.